TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 77)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 SEGMENTS COVERED
FIGURE 1 HIGH THROUGHPUT SCREENING MARKET SEGMENTATION
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY (Page No. - 84)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 3 HIGH THROUGHPUT SCREENING MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2023
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023
FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023
2.2.1 INSIGHTS FROM PRIMARIES
FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 MARKET GROWTH FORECAST
FIGURE 9 HIGH THROUGHPUT SCREENING INDUSTRY: CAGR PROJECTIONS, 2024–2029
FIGURE 10 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ON MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
3 EXECUTIVE SUMMARY (Page No. - 95)
FIGURE 12 HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 13 HIGH THROUGHPUT SCREENING INDUSTRY, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
FIGURE 14 MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15 MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT: MARKET
4 PREMIUM INSIGHTS (Page No. - 99)
4.1 HIGH THROUGHPUT SCREENING MARKET OVERVIEW
FIGURE 17 GROWING ADOPTION OF OPEN INNOVATIVE MODELS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: HIGH THROUGHPUT SCREENING INDUSTRY SHARE, BY OFFERING AND COUNTRY (2023)
FIGURE 18 CONSUMABLES DOMINATED NORTH AMERICAN MARKET IN 2023
4.3 MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 19 CONSUMABLES TO CONTINUE TO DOMINATE MARKET BY 2029
4.4 MARKET SHARE, BY END USER, 2023
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN MARKET FROM 2024 TO 2029
5 MARKET OVERVIEW (Page No. - 103)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 HIGH THROUGHPUT SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 HIGH THROUGHPUT SCREENING INDUSTRY: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing adoption of open innovation models
5.2.1.2 Rising government funding and venture capital investments
5.2.1.3 Increasing R&D spending
FIGURE 23 RISING GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028
5.2.1.4 Technological advancements
5.2.2 RESTRAINTS
5.2.2.1 High cost of using HTS instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing adoption of HTS technologies in emerging markets
5.2.3.2 Growing research on novel therapeutics
5.2.3.3 Drug repurposing
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled operators
5.2.4.2 Complexities in data management, assay development, and analysis
5.3 INDUSTRY TRENDS
5.3.1 ADOPTION OF PHENOTYPIC SCREENING
5.3.2 AUTOMATION AND AI INTEGRATION
5.3.3 RISE OF CRISPR TECHNOLOGY
5.3.4 INTEGRATION OF SINGLE-CELL ANALYSIS TECHNOLOGIES
5.3.5 REGULATORY CONSIDERATIONS
5.4 TECHNOLOGY ANALYSIS
5.4.1 KEY TECHNOLOGIES
5.4.1.1 High-content screening/analysis
5.4.1.2 Label-free detection (surface plasmon resonance)
5.4.2 COMPLEMENTARY TECHNOLOGIES
5.4.2.1 Microfluidics, organ-on-a-chip (OOC), and lab-on-a-chip (LOC)
5.4.2.2 Mass spectrometry (MS)
5.4.2.3 Flow cytometry
5.4.3 ADJACENT TECHNOLOGIES
5.4.3.1 Fragment-based drug discovery
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 REVENUE SHIFT & NEW POCKETS FOR HIGH-THROUGHPUT SCREENING (HTS) SOLUTION PROVIDERS
5.6 PRICING ANALYSIS
TABLE 3 AVERAGE SELLING PRICE FOR HIGH-THROUGHPUT SCREENING PRODUCTS, 2023
TABLE 4 AVERAGE SELLING PRICE FOR HIGH-THROUGHPUT SCREENING PRODUCTS, BY REGION
TABLE 5 INDICATIVE PRICING FOR HIGH-THROUGHPUT SCREENING PRODUCTS, BY REGION, 2021–2023 (USD)
FIGURE 25 PRICING TREND FOR INSTRUMENTS, 2021–2023
5.7 VALUE CHAIN ANALYSIS
FIGURE 26 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING PRODUCT DEVELOPMENT PHASE
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 27 DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
5.9 ECOSYSTEM ANALYSIS
FIGURE 28 ECOSYSTEM ANALYSIS: MARKET
5.9.1 MARKET: ROLE OF RAW MATERIAL VENDORS
TABLE 6 MARKET: ROLE OF RAW MATERIAL VENDORS
5.9.2 MARKET: ROLE OF PRODUCT & SERVICE PROVIDERS
TABLE 7 MARKET: ROLE OF PRODUCT & SERVICE PROVIDERS
5.9.3 MARKET: ROLE OF END USERS
TABLE 8 MARKET: ROLE OF END USERS
5.9.4 MARKET: ROLE OF REGULATORY AUTHORITIES
TABLE 9 MARKET: ROLE OF REGULATORY AUTHORITIES
5.10 PATENT ANALYSIS
TABLE 10 PATENTS FILED, BY DOCUMENT TYPE, 2012–2023
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES) FOR HIGH-THROUGHPUT SCREENING PATENTS (JANUARY 2012–DECEMBER 2023)
TABLE 11 INDICATIVE LIST OF PATENTS IN MARKET
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA FOR SPECTROMETERS
TABLE 12 IMPORT DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 13 IMPORT VOLUME DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
5.11.2 IMPORT DATA FOR MASS SPECTROMETERS
TABLE 14 IMPORT DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2023 (USD THOUSAND)
TABLE 15 IMPORT VOLUME DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2022–2023 (UNITS)
5.11.3 EXPORT DATA FOR SPECTROMETERS
TABLE 16 EXPORT DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 17 EXPORT VOLUME DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
5.11.4 EXPORT DATA FOR MASS SPECTROMETERS
TABLE 18 EXPORT DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 19 EXPORT VOLUME DATA FOR MASS SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)
5.12 REGULATORY ANALYSIS
5.12.1 REGULATORY LANDSCAPE
5.12.1.1 US
5.12.1.2 Europe
5.12.1.3 Emerging markets
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 PORTER’S FIVE FORCES ANALYSIS
TABLE 25 MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 30 MARKET: PORTER’S FIVE FORCES ANALYSIS
5.13.1 INTENSITY OF COMPETITIVE RIVALRY
5.13.2 BARGAINING POWER OF SUPPLIERS
5.13.3 BARGAINING POWER OF BUYERS
5.13.4 THREAT OF SUBSTITUTES
5.13.5 THREAT OF NEW ENTRANTS
5.14 KEY CONFERENCES & EVENTS, 2024–2025
TABLE 26 MARKET: LIST OF CONFERENCES & EVENTS
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS OF HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.15.2 BUYING CRITERIA FOR HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES
FIGURE 31 KEY BUYING CRITERIA FOR END USERS
5.15.3 BUYING CRITERIA FOR HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES, BY END USER
6 HIGH THROUGHPUT SCREENING MARKET, BY OFFERING (Page No. - 148)
6.1 INTRODUCTION
TABLE 27 HIGH THROUGHPUT SCREENING INDUSTRY, BY OFFERING, 2022–2029 (USD MILLION)
6.2 CONSUMABLES
TABLE 28 HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 29 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 30 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 31 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 32 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 33 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 34 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 35 HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
6.2.1 REAGENTS & ASSAY KITS
6.2.1.1 Growing applications of HTS in drug discovery and life science research to support demand for consumables
TABLE 36 MARKET FOR REAGENTS & ASSAY KITS, BY REGION, 2022–2029 (USD MILLION)
TABLE 37 NORTH AMERICA: MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 38 EUROPE: MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 39 ASIA PACIFIC: MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 40 LATIN AMERICA: MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 41 MIDDLE EAST: MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 42 GCC COUNTRIES: MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)
6.2.2 LABORATORY CONSUMABLES
6.2.2.1 Growing automation in high-throughput screening to propel market growth
TABLE 43 MARKET FOR LABORATORY CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)
TABLE 44 NORTH AMERICA: MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 45 EUROPE: MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 46 ASIA PACIFIC: MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 47 LATIN AMERICA: MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 48 MIDDLE EAST: MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 49 GCC COUNTRIES: MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)
6.3 INSTRUMENTS
TABLE 50 HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 51 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 52 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 53 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 55 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 56 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 57 HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
6.3.1 LIQUID HANDLING SYSTEMS
6.3.1.1 Ongoing technological advancements and automation to support market growth
TABLE 58 MARKET FOR LIQUID HANDLING SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
TABLE 59 NORTH AMERICA: MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 60 EUROPE: MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 61 ASIA PACIFIC: MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 LATIN AMERICA: MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 63 MIDDLE EAST: MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 64 GCC COUNTRIES: MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.2 DETECTION SYSTEMS
6.3.2.1 High demand for high-throughput and sensitive detection systems to propel market
TABLE 65 MARKET FOR DETECTION SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
TABLE 66 NORTH AMERICA: MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 EUROPE: MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 68 ASIA PACIFIC: MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 69 LATIN AMERICA: MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 70 MIDDLE EAST: MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 71 GCC COUNTRIES: MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 72 MARKET FOR FLOW CYTOMETRY INSTRUMENTS FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022–2029 (UNITS)
6.3.3 IMAGING INSTRUMENTS
6.3.3.1 Advancements in high-content imaging systems to boost market
TABLE 73 MARKET FOR IMAGING INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 74 NORTH AMERICA: MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 75 EUROPE: MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 76 ASIA PACIFIC: MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 77 LATIN AMERICA: MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 78 MIDDLE EAST: MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 79 GCC COUNTRIES: MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
6.3.4 OTHER INSTRUMENTS
TABLE 80 MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION)
TABLE 81 NORTH AMERICA: MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 82 EUROPE: MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 83 ASIA PACIFIC: MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 84 LATIN AMERICA: MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 MIDDLE EAST: MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 86 GCC COUNTRIES: MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)
6.4 SERVICES
6.4.1 INCREASING ASSAY COMPLEXITIES AND GROWING NEED FOR COST-EFFECTIVE AND SPECIALIZED HTS EXPERTISE TO BOOST DEMAND
TABLE 87 HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 88 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 89 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 90 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 92 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 93 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
6.5 SOFTWARE
6.5.1 ONGOING INTEGRATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING SOFTWARE TOOLS TO DRIVE MARKET
TABLE 94 HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 96 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 97 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 98 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 99 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 100 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
7 HIGH THROUGHPUT SCREENING MARKET, BY APPLICATION (Page No. - 186)
7.1 INTRODUCTION
TABLE 101 HIGH THROUGHPUT SCREENING INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)
7.2 DRUG DISCOVERY
7.2.1 GROWING DEMAND FOR MORE EFFECTIVE METHODS TO IDENTIFY NEW DRUG CANDIDATES TO SUPPORT MARKET GROWTH
TABLE 102 MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 103 NORTH AMERICA: MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 104 EUROPE: MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 105 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 106 LATIN AMERICA: MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 107 MIDDLE EAST: MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 108 GCC COUNTRIES: MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.3 BIOCHEMICAL SCREENING
7.3.1 GROWING AWARENESS OF GENETIC DISORDERS AND SCREENING TESTS TO BOOST MARKET GROWTH
TABLE 109 MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 110 NORTH AMERICA: MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 111 EUROPE: MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 112 ASIA PACIFIC: MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 113 LATIN AMERICA: MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 114 MIDDLE EAST: MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 GCC COUNTRIES: MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.4 LIFE SCIENCE RESEARCH
7.4.1 INCREASING INVESTMENTS IN STEM CELL RESEARCH TO CONTRIBUTE TO MARKET GROWTH
TABLE 116 MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 117 NORTH AMERICA: MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 118 EUROPE: MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 119 ASIA PACIFIC: MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 120 LATIN AMERICA: MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 121 MIDDLE EAST: MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 122 GCC COUNTRIES: MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
7.5 OTHER APPLICATIONS
TABLE 123 MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 124 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 125 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 126 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 127 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 128 MIDDLE EAST: MARKET OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 129 GCC COUNTRIES: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
8 HIGH THROUGHPUT SCREENING MARKET, BY TECHNOLOGY (Page No. - 203)
8.1 INTRODUCTION
TABLE 130 HIGH THROUGHPUT SCREENING v, BY TECHNOLOGY, 2022–2029 (USD MILLION)
8.2 CELL-BASED ASSAYS
TABLE 131 COMPARISON OF 2D AND 3D CELL CULTURES
TABLE 132 MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 133 MARKET FOR CELL-BASED ASSAYS, BY REGION, 2022–2029 (USD MILLION)
TABLE 134 NORTH AMERICA: MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 135 EUROPE: MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 136 ASIA PACIFIC: MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 137 LATIN AMERICA: MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 138 MIDDLE EAST: MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 139 GCC COUNTRIES: MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.1 2D CELL CULTURES
8.2.1.1 Cost-effectiveness of 2D cell cultures to promote market growth
TABLE 140 MARKET FOR 2D CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
TABLE 141 NORTH AMERICA: MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 142 EUROPE: MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 143 ASIA PACIFIC: MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 144 LATIN AMERICA: MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 145 MIDDLE EAST: MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 146 GCC COUNTRIES: MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2 3D CELL CULTURES
TABLE 147 MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 148 MARKET FOR 3D CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
TABLE 149 NORTH AMERICA: MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 150 EUROPE: MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 151 ASIA PACIFIC: MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 152 LATIN AMERICA: MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 153 MIDDLE EAST: MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 154 GCC COUNTRIES: MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.1 Scaffold-based technology
TABLE 155 MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 156 MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 157 NORTH AMERICA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 158 EUROPE: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 159 ASIA PACIFIC: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 160 LATIN AMERICA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 161 MIDDLE EAST: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 162 GCC COUNTRIES: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.1.1 Hydrogels
TABLE 163 MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 164 MARKET FOR HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
TABLE 165 NORTH AMERICA: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 166 EUROPE: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 167 ASIA PACIFIC: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 168 LATIN AMERICA: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 169 MIDDLE EAST: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 170 GCC COUNTRIES: MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.1.1.1 Animal-derived hydrogels
TABLE 171 MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 172 MARKET FOR ANIMAL-DERIVED HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
TABLE 173 NORTH AMERICA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 174 EUROPE: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 175 ASIA PACIFIC: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 176 LATIN AMERICA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 177 MIDDLE EAST: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 178 GCC COUNTRIES: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.1.1.1.1 Matrigel
8.2.2.1.1.1.1.1 Increasing applications of Matrigel in drug discovery and life science research to support market growth
TABLE 179 MARKET FOR MATRIGEL, BY REGION, 2022–2029 (USD MILLION)
TABLE 180 NORTH AMERICA: MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 181 EUROPE: MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 182 ASIA PACIFIC: MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 183 LATIN AMERICA: MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 184 MIDDLE EAST: MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 185 GCC COUNTRIES: MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.1.1.1.2 Collagen
8.2.2.1.1.1.2.1 Growing demand for personalized medicines to support market growth
TABLE 186 MARKET FOR COLLAGEN, BY REGION, 2022–2029 (USD MILLION)
TABLE 187 NORTH AMERICA: MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 188 EUROPE: MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 189 ASIA PACIFIC: MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 190 LATIN AMERICA: MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 191 MIDDLE EAST: MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 192 GCC COUNTRIES: MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.1.1.2 Synthetic hydrogels
8.2.2.1.1.2.1 Better consistency and low risk of contamination to increase adoption and drive growth
TABLE 193 MARKET FOR SYNTHETIC HYDROGELS, BY REGION, 2022–2029 (USD MILLION)
TABLE 194 NORTH AMERICA: MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 195 EUROPE: MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 196 ASIA PACIFIC: MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 197 LATIN AMERICA: MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 198 MIDDLE EAST: MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 199 GCC COUNTRIES: MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.1.1.3 Alginate/Agarose
8.2.2.1.1.3.1 Ability of alginate to enhance accuracy and relevance to propel adoption
TABLE 200 MARKET FOR ALGINATE/AGAROSE, BY REGION, 2022–2029 (USD MILLION)
TABLE 201 NORTH AMERICA: MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 202 EUROPE: MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 203 ASIA PACIFIC: MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 204 LATIN AMERICA: MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 205 MIDDLE EAST: MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 206 GCC COUNTRIES: MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.1.2 Inert matrices/Solid scaffolds
8.2.2.1.2.1 Lack of native-like microenvironment and other disadvantages to restrain growth
TABLE 207 MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY REGION, 2022–2029 (USD MILLION)
TABLE 208 NORTH AMERICA: MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 209 EUROPE: MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 210 ASIA PACIFIC: MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 211 LATIN AMERICA: MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 212 MIDDLE EAST: MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 213 GCC COUNTRIES: MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.1.3 Micropatterned surfaces
8.2.2.1.3.1 Greater enzyme levels and drug reactivity to support adoption
TABLE 214 MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2022–2029 (USD MILLION)
TABLE 215 NORTH AMERICA: MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 216 EUROPE: MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 217 ASIA PACIFIC: MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 218 LATIN AMERICA: MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 219 MIDDLE EAST: MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 220 GCC COUNTRIES: MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.2 Scaffold-free technology
TABLE 221 MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 222 MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 223 NORTH AMERICA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 224 EUROPE: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 225 ASIA PACIFIC: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 226 LATIN AMERICA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 227 MIDDLE EAST: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 228 GCC COUNTRIES: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.2.1 Ultra-low-binding plates
8.2.2.2.1.1 Demand for high-quality, low-background assays to boost market
TABLE 229 MARKET FOR ULTRA-LOW-BINDING PLATES, BY REGION, 2022–2029 (USD MILLION)
TABLE 230 NORTH AMERICA: MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 231 EUROPE: MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 232 ASIA PACIFIC: MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 233 LATIN AMERICA: MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 234 MIDDLE EAST: MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 235 GCC COUNTRIES: MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.2.2 Hanging-drop plates
8.2.2.2.2.1 Cost-effectiveness to boost adoption among end users
TABLE 236 MARKET FOR HANGING-DROP PLATES, BY REGION, 2022–2029 (USD MILLION)
TABLE 237 NORTH AMERICA: MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 238 EUROPE: MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 239 ASIA PACIFIC: MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 240 LATIN AMERICA: MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 241 MIDDLE EAST: MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 242 GCC COUNTRIES: MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.2.2.3 Other scaffold-free technologies
TABLE 243 MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 244 NORTH AMERICA: MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 245 EUROPE: MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 246 ASIA PACIFIC: MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 247 LATIN AMERICA: MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 248 MIDDLE EAST: MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 249 GCC COUNTRIES: MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.3 REPORTER-BASED ASSAYS
8.2.3.1 Growing applications of gene expression to support growth
TABLE 250 MARKET FOR REPORTER-BASED ASSAYS, BY REGION, 2022–2029 (USD MILLION)
TABLE 251 NORTH AMERICA: MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 252 EUROPE: MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 253 ASIA PACIFIC: MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 254 LATIN AMERICA: MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 255 MIDDLE EAST: MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 256 GCC COUNTRIES: MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)
8.2.4 PERFUSION CELL CULTURES
8.2.4.1 Ongoing research to develop perfusion cell culture technology for drug discovery to support adoption
TABLE 257 MARKET FOR PERFUSION CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)
TABLE 258 NORTH AMERICA: MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 259 EUROPE: MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 260 ASIA PACIFIC: MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 261 LATIN AMERICA: MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 262 MIDDLE EAST: MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 263 GCC COUNTRIES: MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)
8.3 LAB-ON-A-CHIP
8.3.1 INCREASING APPLICATIONS OF LAB-ON-A-CHIP TECHNOLOGY FOR HTS AND PRECISION MEDICINE DEVELOPMENT TO SUPPORT MARKET GROWTH
TABLE 264 MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 265 NORTH AMERICA: MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 266 EUROPE: MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 267 ASIA PACIFIC: MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 268 LATIN AMERICA: MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 269 MIDDLE EAST: MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 270 GCC COUNTRIES: MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
8.4 LABEL-FREE TECHNOLOGY
8.4.1 ABILITY TO CONDUCT LABEL-FREE INVESTIGATION OF BIOMOLECULAR INTERACTIONS TO PROPEL ADOPTION
TABLE 271 MARKET FOR LABEL-FREE TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
TABLE 272 NORTH AMERICA: MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 273 EUROPE: MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 274 ASIA PACIFIC: MARKET LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 275 LATIN AMERICA: MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 276 MIDDLE EAST: MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 277 GCC COUNTRIES: MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)
9 HIGH THROUGHPUT SCREENING MARKET, BY END USER (Page No. - 277)
9.1 INTRODUCTION
TABLE 278 HIGH THROUGHPUT SCREENING INDUSTRY (HTS), BY END USER, 2022–2029 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 GROWING DEMAND FOR HTS SOLUTIONS IN LEAD DISCOVERY TO SUPPORT MARKET GROWTH
TABLE 279 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 280 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 281 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 282 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 283 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 284 MIDDLE EAST: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 285 GCC COUNTRIES: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
9.3 ACADEMIC & RESEARCH INSTITUTES
9.3.1 GROWING ADOPTION OF HTS IN COLLABORATIVE ACADEMIC & RESEARCH ACTIVITIES TO AID MARKET GROWTH
TABLE 286 MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 287 NORTH AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 288 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 289 ASIA PACIFIC: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 290 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 291 MIDDLE EAST: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 292 GCC COUNTRIES: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
9.4 CONTRACT RESEARCH ORGANIZATIONS (CROS)
9.4.1 INCREASING OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH FOR CROS
TABLE 293 MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 294 NORTH AMERICA: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 295 EUROPE: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 296 ASIA PACIFIC: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 297 LATIN AMERICA: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 298 MIDDLE EAST: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 299 GCC COUNTRIES: MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
9.5 OTHER END USERS
TABLE 300 MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 301 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 302 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 303 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 304 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 305 MIDDLE EAST: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 306 GCC COUNTRIES: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
10 HIGH THROUGHPUT SCREENING MARKET, BY REGION (Page No. - 293)
10.1 INTRODUCTION
TABLE 307 HIGH THROUGHPUT SCREENING INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 32 NORTH AMERICA: HIGH THROUGHPUT SCREENING MARKET SNAPSHOT
TABLE 308 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 309 NORTH AMERICA: MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 310 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 311 NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 312 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 313 NORTH AMERICA: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 314 NORTH AMERICA: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 315 NORTH AMERICA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 316 NORTH AMERICA: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 317 NORTH AMERICA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 318 NORTH AMERICA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 319 NORTH AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 320 NORTH AMERICA: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.2.2 US
10.2.2.1 Presence of major research institutes and key pharmaceutical companies to support market growth
TABLE 321 US: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 322 US: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 323 US: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 324 US: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 325 US: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 326 US: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 327 US: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 328 US: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 329 US: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 330 US: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 331 US: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 332 US: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Government initiatives promoting research to support market growth
TABLE 333 CANADA: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 334 CANADA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 335 CANADA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 336 CANADA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 337 CANADA: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 338 CANADA: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 339 CANADA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 340 CANADA: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 341 CANADA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 342 CANADA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 343 CANADA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 344 CANADA: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3 EUROPE
10.3.1 EUROPE: RECESSION IMPACT
TABLE 345 EUROPE: HIGH THROUGHPUT SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 346 EUROPE: MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 347 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 348 EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 349 EUROPE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 350 EUROPE: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 351 EUROPE: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 352 EUROPE: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 353 EUROPE: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 354 EUROPE: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 355 EUROPE: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 356 EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 357 EUROPE: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.2 GERMANY
10.3.2.1 Increasing research initiatives to boost market growth
TABLE 358 GERMANY: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 359 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 360 GERMANY: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 361 GERMANY: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 362 GERMANY: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 363 GERMANY: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 364 GERMANY: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 365 GERMANY: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 366 GERMANY: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 367 GERMANY: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 368 GERMANY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 369 GERMANY: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.3 UK
10.3.3.1 Investments by pharmaceutical sponsors for drug discovery to support market
TABLE 370 UK: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 371 UK: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 372 UK: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 373 UK: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 374 UK: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 375 UK: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 376 UK: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 377 UK: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 378 UK: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 379 UK: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 380 UK: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 381 UK: MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.4 FRANCE
10.3.4.1 Large pharmaceutical R&D expenditure to drive market growth
TABLE 382 FRANCE: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 383 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 384 FRANCE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 385 FRANCE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 386 FRANCE: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 387 FRANCE: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 388 FRANCE: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 389 FRANCE: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 390 FRANCE: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 391 FRANCE: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 392 FRANCE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 393 FRANCE: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Strong collaborative research networks to fuel growth
TABLE 394 ITALY: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 395 ITALY: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 396 ITALY: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 397 ITALY: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 398 ITALY: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 399 ITALY: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 400 ITALY: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 401 ITALY: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 402 ITALY: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 403 ITALY: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 404 ITALY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 405 ITALY: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Rising R&D expenditure and increasing public-private partnerships to boost market
TABLE 406 SPAIN: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 407 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 408 SPAIN: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 409 SPAIN: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 410 SPAIN: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 411 SPAIN: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 412 SPAIN: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 413 SPAIN: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 414 SPAIN: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 415 SPAIN: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 416 SPAIN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 417 SPAIN: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 418 REST OF EUROPE: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 419 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 420 REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 421 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 422 REST OF EUROPE: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 423 REST OF EUROPE: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 424 REST OF EUROPE: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 425 REST OF EUROPE: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 426 REST OF EUROPE: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 427 REST OF EUROPE: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 428 REST OF EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 429 REST OF EUROPE: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 33 ASIA PACIFIC: HIGHT-THROUGHPUT SCREENING (HTS) MARKET SNAPSHOT
TABLE 430 ASIA PACIFIC: HIGH THROUGHPUT SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 431 ASIA PACIFIC: MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 432 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 433 ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 434 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 435 ASIA PACIFIC: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 436 ASIA PACIFIC: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 437 ASIA PACIFIC: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 438 ASIA PACIFIC: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 439 ASIA PACIFIC: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 440 ASIA PACIFIC: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 441 ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 442 ASIA PACIFIC: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Growing research and collaborations in field of drug discovery to support growth of market
TABLE 443 CHINA: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 444 CHINA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 445 CHINA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 446 CHINA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 447 CHINA: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 448 CHINA: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 449 CHINA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 450 CHINA: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 451 CHINA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 452 CHINA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 453 CHINA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 454 CHINA: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 Growing focus on research and strategic collaborations to support market growth
TABLE 455 JAPAN: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 456 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 457 JAPAN: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 458 JAPAN: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 459 JAPAN: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 460 JAPAN: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 461 JAPAN: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 462 JAPAN: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 463 JAPAN: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 464 JAPAN: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 465 JAPAN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 466 JAPAN: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Developing healthcare industry and ongoing government initiatives to create favorable opportunities for market players
TABLE 467 INDIA: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 468 INDIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 469 INDIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 470 INDIA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 471 INDIA: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 472 INDIA: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 473 INDIA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 474 INDIA: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 475 INDIA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 476 INDIA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 477 INDIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 478 INDIA: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Growing pharmaceutical industry to create favorable opportunities for market players
TABLE 479 AUSTRALIA: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 480 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 481 AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 482 AUSTRALIA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 483 AUSTRALIA: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 484 AUSTRALIA: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 485 AUSTRALIA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 486 AUSTRALIA: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 487 AUSTRALIA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 488 AUSTRALIA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 489 AUSTRALIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 490 AUSTRALIA: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.6 SOUTH KOREA
10.4.6.1 Growing pharmaceutical industry to favor market growth
TABLE 491 SOUTH KOREA: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 492 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 493 SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 494 SOUTH KOREA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 495 SOUTH KOREA: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 496 SOUTH KOREA: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 497 SOUTH KOREA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 498 SOUTH KOREA: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 499 SOUTH KOREA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 500 SOUTH KOREA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 501 SOUTH KOREA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 502 SOUTH KOREA: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC (ROAPAC)
TABLE 503 REST OF ASIA PACIFIC: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 504 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 505 REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 506 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 507 REST OF ASIA PACIFIC: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 508 REST OF ASIA PACIFIC: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 509 REST OF ASIA PACIFIC: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 510 REST OF ASIA PACIFIC: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 511 REST OF ASIA PACIFIC: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 512 REST OF ASIA PACIFIC: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 513 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 514 REST OF ASIA PACIFIC: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 515 LATIN AMERICA: HIGH THROUGHPUT SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 516 LATIN AMERICA: MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 517 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 518 LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 519 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 520 LATIN AMERICA: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 521 LATIN AMERICA: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 522 LATIN AMERICA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 523 LATIN AMERICA: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 524 LATIN AMERICA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 525 LATIN AMERICA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 526 LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 527 LATIN AMERICA: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.5.2 BRAZIL
10.5.2.1 Gradual growth in research to contribute to growth
TABLE 528 BRAZIL: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 529 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 530 BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 531 BRAZIL: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 532 BRAZIL: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 533 BRAZIL: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 534 BRAZIL: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 535 BRAZIL: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 536 BRAZIL: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 537 BRAZIL: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 538 BRAZIL: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 539 BRAZIL: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.5.3 MEXICO
10.5.3.1 Favorable government support to contribute to growth
TABLE 540 MEXICO: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 541 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 542 MEXICO: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 543 MEXICO: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 544 MEXICO: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 545 MEXICO: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 546 MEXICO: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 547 MEXICO: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 548 MEXICO: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 549 MEXICO: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 550 MEXICO: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 551 MEXICO: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.5.4 REST OF LATIN AMERICA
TABLE 552 REST OF LATIN AMERICA: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 553 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 554 REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 555 REST OF LATIN AMERICA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 556 REST OF LATIN AMERICA: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 557 REST OF LATIN AMERICA: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 558 REST OF LATIN AMERICA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 559 REST OF LATIN AMERICA: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 560 REST OF LATIN AMERICA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 561 REST OF LATIN AMERICA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 562 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 563 REST OF LATIN AMERICA: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.6 MIDDLE EAST
10.6.1 MIDDLE EAST: RECESSION IMPACT
TABLE 564 MIDDLE EAST: HIGH THROUGHPUT SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 565 MIDDLE EAST: MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 566 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 567 MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 568 MIDDLE EAST: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 569 MIDDLE EAST: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 570 MIDDLE EAST: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 571 MIDDLE EAST: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 572 MIDDLE EAST: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 573 MIDDLE EAST: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 574 MIDDLE EAST: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 575 MIDDLE EAST: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 576 MIDDLE EAST: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.6.2 GCC COUNTRIES
TABLE 577 GCC COUNTRIES: HIGH THROUGHPUT SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 578 GCC COUNTRIES: MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 579 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 580 GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 581 GCC COUNTRIES: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 582 GCC COUNTRIES: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 583 GCC COUNTRIES: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 584 GCC COUNTRIES: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 585 GCC COUNTRIES: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 586 GCC COUNTRIES: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 587 GCC COUNTRIES: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 588 GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 589 GCC COUNTRIES: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.6.2.1 Saudi Arabia
10.6.2.1.1 Growing pharmaceuticals industry to support market growth
TABLE 590 SAUDI ARABIA: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 591 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 592 SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 593 SAUDI ARABIA: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 594 SAUDI ARABIA: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 595 SAUDI ARABIA: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 596 SAUDI ARABIA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 597 SAUDI ARABIA: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 598 SAUDI ARABIA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 599 SAUDI ARABIA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 600 SAUDI ARABIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 601 SAUDI ARABIA: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.6.2.2 UAE
10.6.2.2.1 High R&D expenditure and advanced healthcare infrastructure to boost market growth
TABLE 602 UNITED ARAB EMIRATES: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 603 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 604 UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 605 UNITED ARAB EMIRATES: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 606 UNITED ARAB EMIRATES: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 607 UNITED ARAB EMIRATES: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 608 UNITED ARAB EMIRATES: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 609 UNITED ARAB EMIRATES: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 610 UNITED ARAB EMIRATES: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 611 UNITED ARAB EMIRATES: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 612 UNITED ARAB EMIRATES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 613 UNITED ARAB EMIRATES: MARKET, BY END USER, 2022–2029 (USD MILLION)
10.6.2.3 Rest of GCC Countries
TABLE 614 REST OF GCC COUNTRIES: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 615 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 616 REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 617 REST OF GCC COUNTRIES: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 618 REST OF GCC COUNTRIES: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 619 REST OF GCC COUNTRIES: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 620 REST OF GCC COUNTRIES: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 621 REST OF GCC COUNTRIES: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 622 REST OF GCC COUNTRIES: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 623 REST OF GCC COUNTRIES: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 624 REST OF GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 625 REST OF GCC COUNTRIES: MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 626 REST OF MIDDLE EAST: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 627 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 628 REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 629 REST OF MIDDLE EAST: MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 630 REST OF MIDDLE EAST: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 631 REST OF MIDDLE EAST: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 632 REST OF MIDDLE EAST: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 633 REST OF MIDDLE EAST: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 634 REST OF MIDDLE EAST: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 635 REST OF MIDDLE EAST: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 636 REST OF MIDDLE EAST: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 637 REST OF MIDDLE EAST: HIGH THROUGHPUT SCREENING MARKET, BY END USER, 2022–2029 (USD MILLION)
10.7 AFRICA
10.7.1 INCREASING FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO AID MARKET GROWTH
10.7.2 AFRICA: RECESSION IMPACT
TABLE 638 AFRICA: HIGH THROUGHPUT SCREENING MARKET, BY OFFERING, 2022–2029 (USD MILLION)
TABLE 639 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 640 AFRICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 641 AFRICA: HIGH THROUGHPUT SCREENING INDUSTRY, BY TECHNOLOGY, 2022–2029 (USD MILLION)
TABLE 642 AFRICA: MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 643 AFRICA: MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)
TABLE 644 AFRICA: MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 645 AFRICA: MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 646 AFRICA: MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)
TABLE 647 AFRICA: MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)
TABLE 648 AFRICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 649 AFRICA: HIGH THROUGHPUT SCREENING INDUSTRY, BY END USER, 2022–2029 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 435)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HIGH THROUGHPUT SCREENING MARKET
TABLE 650 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HIGH THROUGHPUT SCREENING MARKET
11.3 REVENUE ANALYSIS
FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD MILLION)
11.4 MARKET SHARE ANALYSIS
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
TABLE 651 HIGH THROUGHPUT SCREENING MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 36 HIGH THROUGHPUT SCREENING INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
FIGURE 37 HIGH THROUGHPUT SCREENING INDUSTRY: COMPANY FOOTPRINT
11.5.5.2 Offering footprint
TABLE 652 HIGH THROUGHPUT SCREENING INDUSTRY: OFFERING FOOTPRINT
11.5.5.3 Application footprint
TABLE 653 HIGH THROUGHPUT SCREENING INDUSTRY: APPLICATION FOOTPRINT
11.5.5.4 Region footprint
TABLE 654 HIGH THROUGHPUT SCREENING INDUSTRY: REGION FOOTPRINT
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 38 HIGH THROUGHPUT SCREENING INDUSTRY: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
TABLE 655 HIGH THROUGHPUT SCREENING INDUSTRY: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 656 HIGH THROUGHPUT SCREENING INDUSTRY: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
FIGURE 39 EV/EBITDA OF KEY VENDORS
11.7.2 COMPANY VALUATION
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
11.8 BRAND/PRODUCT COMPARISON
FIGURE 41 MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES
TABLE 657 MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024
11.9.2 DEALS
TABLE 658 MARKET: DEALS, JANUARY 2021–MAY 2024
11.9.3 EXPANSIONS
TABLE 659 MARKET: EXPANSIONS, JANUARY 2021–MAY 2024
12 COMPANY PROFILES (Page No. - 458)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 660 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 42 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
TABLE 661 THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED
TABLE 662 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS
TABLE 663 THERMO FISHER SCIENTIFIC INC.: DEALS
TABLE 664 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
12.1.2 AGILENT TECHNOLOGIES, INC.
TABLE 665 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 43 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
TABLE 666 AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 667 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & UPGRADES
TABLE 668 AGILENT TECHNOLOGIES, INC.: DEALS
12.1.3 MERCK KGAA
TABLE 669 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 44 MERCK KGAA: COMPANY SNAPSHOT (2023)
TABLE 670 MERCK KGAA: PRODUCTS & SERVICES OFFERED
TABLE 671 MERCK KGAA: OTHER DEVELOPMENTS
12.1.4 DANAHER CORPORATION
TABLE 672 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 673 DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 674 DANAHER CORPORATION: PRODUCT & SERVICE LAUNCHES
TABLE 675 DANAHER CORPORATION: DEALS
TABLE 676 DANAHER CORPORATION: EXPANSIONS
12.1.5 REVVITY, INC.
TABLE 677 REVVITY, INC.: BUSINESS OVERVIEW
FIGURE 46 REVVITY, INC.: COMPANY SNAPSHOT (2023)
TABLE 678 REVVITY INC.: PRODUCTS & SERVICES OFFERED
TABLE 679 REVVITY, INC.: PRODUCT LAUNCHES
TABLE 680 REVVITY, INC.: DEALS
12.1.6 TECAN GROUP LTD.
TABLE 681 TECAN GROUP LTD.: BUSINESS OVERVIEW
FIGURE 47 TECAN GROUP LTD. COMPANY SNAPSHOT (2023)
TABLE 682 TECAN GROUP LTD.: PRODUCTS & SERVICES OFFERED
TABLE 683 TECAN GROUP LTD.: PRODUCT LAUNCHES & UPGRADES
TABLE 684 TECAN GROUP LTD.: DEALS
12.1.7 BIO-RAD LABORATORIES, INC.
TABLE 685 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 48 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
TABLE 686 BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED
TABLE 687 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES
12.1.8 CORNING INCORPORATED
TABLE 688 CORNING INCORPORATED: BUSINESS OVERVIEW
FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
TABLE 689 CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED
TABLE 690 CORNING INCORPORATED: PRODUCT LAUNCHES
12.1.9 METTLER-TOLEDO INTERNATIONAL INC.
TABLE 691 METTLER-TOLEDO INTERNATIONAL INC.: BUSINESS OVERVIEW
FIGURE 50 METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2023)
TABLE 692 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED
TABLE 693 METTLER-TOLEDO INTERNATIONAL INC.: PRODUCT LAUNCHES
12.1.10 LONZA GROUP
TABLE 694 LONZA GROUP: BUSINESS OVERVIEW
FIGURE 51 LONZA GROUP: COMPANY SNAPSHOT (2023)
TABLE 695 LONZA GROUP: PRODUCTS & SERVICES OFFERED
TABLE 696 LONZA GROUP: DEALS
12.1.11 WATERS CORPORATION
TABLE 697 WATERS CORPORATION: BUSINESS OVERVIEW
FIGURE 52 WATERS CORPORATION: COMPANY SNAPSHOT (2023)
TABLE 698 WATERS CORPORATION: PRODUCTS & SERVICES OFFERED
TABLE 699 WATERS CORPORATION: PRODUCT LAUNCHES
TABLE 700 WATERS CORPORATION: DEALS
12.1.12 SARTORIUS AG
TABLE 701 SARTORIUS AG: BUSINESS OVERVIEW
FIGURE 53 SARTORIUS AG: COMPANY SNAPSHOT (2023)
TABLE 702 SARTORIUS AG: PRODUCTS & SERVICES OFFERED
TABLE 703 SARTORIUS AG: PRODUCT LAUNCHES
12.1.13 EPPENDORF SE
TABLE 704 EPPENDORF SE: BUSINESS OVERVIEW
FIGURE 54 EPPENDORF SE: COMPANY SNAPSHOT (2023)
TABLE 705 EPPENDORF SE: PRODUCTS & SERVICES OFFERED
TABLE 706 EPPENDORF SE: DEALS
TABLE 707 EPPENDORF SE: EXPANSIONS
12.1.14 PORVAIR PLC
TABLE 708 PORVAIR PLC: BUSINESS OVERVIEW
FIGURE 55 PORVAIR PLC: COMPANY SNAPSHOT (2023)
TABLE 709 PORVAIR PLC: PRODUCTS & SERVICES OFFERED
12.1.15 GREINER AG
TABLE 710 GREINER AG: BUSINESS OVERVIEW
FIGURE 56 GREINER AG: COMPANY SNAPSHOT (2023)
TABLE 711 GREINER AG: PRODUCTS & SERVICES OFFERED
12.1.16 CHARLES RIVER LABORATORIES
TABLE 712 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW
FIGURE 57 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2023)
TABLE 713 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCTS & SERVICES OFFERED
TABLE 714 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: DEALS
12.1.17 EUROFINS SCIENTIFIC
TABLE 715 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 58 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
TABLE 716 EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED
TABLE 717 EUROFINS SCIENTIFIC: SERVICE LAUNCHES
TABLE 718 EUROFINS SCIENTIFIC: DEALS
TABLE 719 EUROFINS SCIENTIFIC: EXPANSIONS
12.1.18 HAMILTON COMPANY
TABLE 720 HAMILTON COMPANY: BUSINESS OVERVIEW
TABLE 721 HAMILTON COMPANY: PRODUCTS & SERVICES OFFERED
TABLE 722 HAMILTON COMPANY: PRODUCT LAUNCHES
TABLE 723 HAMILTON COMPANY: DEALS
12.1.19 AURORA BIOMED INC.
TABLE 724 AURORA BIOMED INC.: BUSINESS OVERVIEW
TABLE 725 AURORA BIOMED INC.: PRODUCTS & SERVICES OFFERED
12.1.20 GILSON INCORPORATED
TABLE 726 GILSON INCORPORATED: BUSINESS OVERVIEW
TABLE 727 GILSON INCORPORATED: PRODUCTS & SERVICES OFFERED
TABLE 728 GILSON INCORPORATED.: PRODUCT LAUNCHES
TABLE 729 GILSON INCORPORATED: DEALS
12.1.21 BRAND GMBH + CO KG
TABLE 730 BRAND GMBH + CO KG: BUSINESS OVERVIEW
TABLE 731 BRAND GMBH + CO KG: PRODUCTS & SERVICES OFFERED
TABLE 732 BRAND GMBH + CO KG: EXPANSIONS
12.2 OTHER PLAYERS
12.2.1 BMG LABTECH GMBH
12.2.2 DIANA BIOTECHNOLOGIES, A.S.
12.2.3 CREATIVE BIOLABS
12.2.4 HIGHRES BIOSOLUTIONS
12.2.5 BIOMAT SRL
12.2.6 AXXAM S.P.A.
12.2.7 SYGNATURE DISCOVERY LIMITED
12.2.8 CROWN BIOSCIENCE
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 569)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
Growth opportunities and latent adjacency in High Throughput Screening Market